Department of Primary Health Care, Sahlgrenska Academy
Gothenburg, Region Västra Götaland, 40530, Sweden
NCT Number: NCT03250026
This study aims to evaluate whether a convergence dialogue during sick leave, between the employee and the employer, with the Primary Care Centre Rehab Coordinator as discussion leader, leads to reduced sick leave time compared to those individuals who only have contact with a Care Manager during the period of sick leave. The study will be performed as a randomised controlled trial with randomisation at the PCC level where intervention PCCs offers a convergence dialogue meeting with the work place representative during sick leave in addition to Care Manager contact.
This study is active but is not currently recruiting participants.
18 year–67 year
All sexes
Interventional
Not applicable
Gothenburg, Region Västra Götaland, 40530, Sweden
In Sweden sick leave time and frequency are increasing. This is primarily in the area of common mental disorders (CMD), and CMD is now the most common single cause of sickness absence. Primary care is the area in which most individuals with mental illness seek care and also receive care. A Care Manager function at the primary care centre (PCC) where the Care Manager is responsible for the support and close contact with patients with CMD and act as the "spider in the web" and combine patient support with other measures, have been shown to have beneficial effects for depression course. In Region Västra Götaland an implementation of the Care Manager function at the PCC has been set out, and the function is now available in nearly 100 PCCs in the region. The present study aims to evaluate whether a convergence dialogue during sick leave, between the employee and the employer, with the PCCs Rehab Coordinator as discussion leader, leads to reduced sick leave time compared to those individuals who only have contact with the Care Manager during the period of sick leave. The study will be performed as pragmatic randomised controlled trial with randomisation at the PCC level. Around 20 PCCs with a Care Manager function for patients on sick-leave with CMD diagnosis will be recruited and randomized to intervention where patients in addition to a Care Manager contact (12 weeks) will have one convergence dialogue meeting with the work place representative during sick leave. Control PCCs will give Care Manager contact 12 weeks only.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients attending primary care centers with care manager function
Exclusion criteria
Work place contact as a convergence dialogue between the employer and employee with the Rehab Coordinator as a guide
Regular contact Care Manager during around 12 weeks
Time frame: 12 months
number of net and gross sick-leave days during 12 months
Time frame: 6 and 12 months
Change of depressive symptoms Montgomery-Asberg Depression Rating Scale - Self rating version (MADRS-S) Range 0-60 (Total score) Low score better outcome
Time frame: 6 and 12 months
Change of anxiety symptoms Generalized Anxiety Disorder 7-item (GAD-7) scale Range 0-15 (total score) low score better outcome
Time frame: 6 and 12 months
Change of quality of life EuroQoL-5 Dimension Questionnaire(EQ-5D) Range 0-1.0(total score) low score worst outcome
Time frame: 6 and 12 months
Change of work ability Work Ability Index (WAI) Range 7-49 (total score) low score worst outcome
Time frame: 6 and 12 months
Change of Exhaustion Karolinska Exhaustion Disorder Scale (KEDS) Range 0-54 (total score) low score better outcome
Göteborg University
Other
Cooperation for Patients With Common Mental Disorders: Care Manager Function at the Primary Care Centre and Intervention at the Workplace - CO-WORK-CARE
Acronym: CO-WORK-CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06671158
Anxiety Disorders, Depressive Disorder
Roanoke, Virginia, United States
View Trial DetailsNCT05400252
Anxiety Disorders, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT06440460
Anxiety Disorders, Anxiety State
Freetown, Sierra Leone
View Trial DetailsNCT05551468
Anxiety Disorders, Behavior
Boekel, Netherlands
View Trial Details